Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Celiac Disease Treatment Market?
The market size for celiac disease treatment has seen robust growth in recent times. Its value is anticipated to increase from $0.61 billion in 2024 to $0.67 billion in 2025, yielding a compound annual growth rate (CAGR) of 9.9%. Factors contributing to the growth experienced in the historic period include a growing prevalence of celiac disease, higher rates of awareness and diagnosis, an increase in demand for non-diet based treatment alternatives, a solid pipeline of innovative therapies, favorable regulatory policies, and enhanced investment by pharmaceutical firms.
What Growth Rate Is Forecasted for the Celiac Disease Treatment Market by 2029?
In the coming years, the market for celiac disease treatment is projected to undergo significant growth, ballooning to $0.96 billion by 2029 with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this market growth in the forecasted period are numerous, and include an increased worldwide incidence of celiac disease, rising diagnostic rates, and expanding awareness. Other influential contributors are the progression of clinical trials examining new treatments, burgeoning demand for alternatives to gluten, regulatory initiatives that support treatment of orphan diseases, and a general increase in healthcare spending. The forecast period is also set to be marked by numerous trends, including the embrace of innovative non-dietary treatments, improvement in enzyme supplement technologies, an increased focus on personalized medicines, the development of immunotherapies based on peptides, enhancements to diagnostic tools, and advancements in clinical trials.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
Which Key Companies Are Shaping the Future of the Celiac Disease Treatment Market?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Which Factors Are Driving Demand in the Celiac Disease Treatment Industry?
The increasing instances of diabetes are predicted to fuel the expansion of the celiac disease treatment market. Diabetes, a persistent health disorder, is characterized by the body’s failure to maintain appropriate blood sugar, or glucose, levels. The rising occurrence of diabetes is attributed to matching dietary control requirements, as both diabetes and celiac disease necessitate precise oversight of food consumption to monitor blood sugar levels and prevent side effects. Celiac disease therapy facilitates diabetes by endorsing a gluten-free diet, thereby enhancing overall digestive wellness and nutrient assimilation. This fosters improved blood sugar regulation and minimizes complications in individuals dealing with both ailments. For example, in June 2024, the UK-based governmental department, the National Health Service, reported that approximately 3,615,330 individuals enlisted with a general practitioner (GP) were identified with non-diabetic hyperglycemia or prediabetes in 2023, marking an 18% rise from the 3,065,825 cases recorded in 2022. Therefore, the escalating prevalence of diabetes is orchestrating the growth of the celiac disease treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
How Is the Celiac Disease Treatment Market Segmented by Several Divisions?
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies
What are the Emerging Market Trends Driving the Growth of the Celiac Disease Treatment Industry?
Leading market players in the celiac disease treatment sector are prioritizing the development of oral therapies like small molecule therapies that provide focused relief by inhibiting gluten-induced immune responses, enhance patient compliance, and present options beyond stringent gluten-free diets. Essentially, small molecule therapies represent minuscule drugs capable of easy cellular penetration to target and attenuate disease-triggering proteins or enzymes. For example, Immunic Inc., a biotech firm based in the US, introduced IMU-856 in February 2025, which is a small molecule that boosts the levels of endogenous glucagon-like peptide-1 (GLP-1), thereby bolstering the intestinal barrier function in patients with celiac disease. It further optimizes nutrient absorption and mitigates symptoms without dampening immune activity.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
Which Regions Are Driving Growth in the Celiac Disease Treatment Market?
North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp
This Report Delivers Insight On:
1. How big is the celiac disease treatment market, and how is it changing globally?
2. Who are the major companies in the celiac disease treatment market, and how are they performing?
3. What are the key opportunities and risks in the celiac disease treatment market right now?
4. Which products or customer segments are growing the most in the celiac disease treatment market?
5. What factors are helping or slowing down the growth of the celiac disease treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model